Director · Keros Therapeutics, Inc. · Common Stock
Side
D
Value
$2.32M
Shares
130.5K
Price
$17.75
Executed
Nov 21, 2025
Disclosed
Dec 18, 2025
Disclosure timeline27 days from execution to publication · legal deadline 2 business days
Nov 21 executedDec 18, 2025 disclosed
KROS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+10 / 25
$2.3M reported value · new position
Filing timing+10 / 15
Disclosed 19 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Knowles Julius filed this Form 4 reporting a disposition to issuer of KROS on Nov 21, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Knowles Juliuscik:0001808365
Issuer
Keros Therapeutics, Inc.cik:0001664710
Revision history · 0
No field has changed since this record was first ingested.
